Emgality Patient Banner Ad: Imagine More Migraine-Free Days
![](https://oncedailypharma.com/wp-content/uploads/2019/06/emgality_1.jpg)
Brand: Emgality (galcanezumab-gnlm), Injection
Parent Company: Eli Lilly
Drug Type: Prescription
Drug Category: Neurology
Campaign: Post-Launch
Targeting: Patients, Caregivers
Patient Website: https://www.emgality.com/
HCP Website: https://www.emgality.com/hcp